Stuck in the Middle: Welfare Effects of the European Pharmaceutical Markets' Incomplete Integration and a Possible Remedy

Peter Kotzian

Abstract: The paper focuses on the regulation and parallel trade for innovative in-patent medicines in the setting of a partially integrated EU-wide market for pharmaceuticals, the impact of different national and European level regulatory regimes, under which the prices for theses innovative medicines are set, on the strategic entry decisions of research oriented pharmaceutical enterprises (ROPEs), the consequences thereof for the innovative capacity of the European pharmaceutical industry and the overall welfare of the European citizens.

Keywords: acquis communautaire; differentiated integration; economic integration; Europeanization; model simulations; harmonisation; industrial policy; industrial relations; national interest; regulatory politics; sectoral governance; Single Market; political economy; policy analysis (search for similar items in EconPapers)
Date: 2002-10-31
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.mzes.uni-mannheim.de/publications/wp/erpa/wp-59.html Abstract (text/html)
http://www.mzes.uni-mannheim.de/publications/wp/erpa/../wp-59.pdf Full text (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:erp:mzesxx:p0031

Access Statistics for this paper

More papers in MZES Working Papers from MZES Contact information at EDIRC.
Bibliographic data for series maintained by Christian Melbeck ( this e-mail address is bad, please contact ).